ADMA Biologics, Inc.
Status: Publicly traded
Direct answer
ADMA Biologics, Inc. is publicly traded on NASDAQ under the ticker ADMA.
ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV,...
Can you invest in ADMA Biologics, Inc.?
Yes. ADMA Biologics, Inc. trades publicly on NASDAQ as ADMA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for ADMA Biologics, Inc.
Detailed equity research is provided by MarketSnap.